NKX2-1 and acute lymphoblastic leukemia: Cytogenetic analysis coupled with gene expression profiling has been used to classify T-ALL into several subgroups: TAL1/LMO1/2-, TLX1/3-, HOXA/MEISI-, LMO2/LYL1, and NKX2-1-positive T-ALL cases (25–27).